You are spot on. When the FDA recognise IMU as a real McCoy, so will most BPs. Just a matter of time when which BPs is going to recognise that without IMU, they could suffer big time in the oncology space.
And right now, there will be nothing better than the next batch of data showing those patients on PR, SD and PD improving further. A few more CRs would be most welcome.
Ann: FDA Fast Track Designation Granted for VAXINIA Trial Program, page-146
-
- There are more pages in this discussion • 267 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
